Different ophthalmologic manifestations of sarcoidosis

Current Opinion in Ophthalmology

Volumn 23, Issue 6, 2012, Pages 477-484

  Umur, Kayabasi A ^a   Tayfun, Bavbek ^a   Oguzhan, Onultan ^b  

^a Dunya Goz Hospital   (Turkey)

^b Anadolu Saglik Merkezi Hospital   (Turkey)

Author keywords

Horner's; methotrexate; optic neuropathy; sarcoidosis

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; DIPEPTIDYL CARBOXYPEPTIDASE; ETANERCEPT; GALLIUM; HLA ANTIGEN; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; PLACEBO; PREDNISONE;

ADULT; ANISOCORIA; ANTERIOR EYE CHAMBER; ANTIINFLAMMATORY ACTIVITY; CASE REPORT; CHORIORETINITIS; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG HYPERSENSITIVITY; DRUG INDICATION; EYE DISEASE; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; FUNCTIONAL NEUROIMAGING; GENOTYPE; HORNER SYNDROME; HUMAN; INFLAMMATION; INTERMEDIATE UVEITIS; IRIDOCYCLITIS; LOW DRUG DOSE; LYMPHADENOPATHY; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCULAR SARCOIDOSIS; OPTIC NERVE; OPTIC NERVE DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETINA MACULA CYSTOID EDEMA; RETINA NEOVASCULARIZATION; REVIEW; SARCOIDOSIS; TRABECULAR MESHWORK; UVEITIS; VISUAL ACUITY; VITRECTOMY; VITREOUS HEMORRHAGE;

ADULT; BIOPSY; FEMALE; HORNER SYNDROME; HUMANS; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE; OPTIC NERVE DISEASES; PARS PLANITIS; SARCOIDOSIS; UVEITIS, POSTERIOR;

EID: 84867846068     PISSN: 10408738     EISSN: 15317021     Source Type: Journal    
DOI: 10.1097/ICU.0b013e328358c7a6     Document Type: Review

References (78)

1. Wallen EB, Youngberg GA. Images in clinical medicine. Blastomycosis. N Engl J Med 1997; 336:1223-11223.
2. Rothova A. Ocular involvement in sarcoidosis. Br J Ophthalmol 2000; 84:110-116. (Pubitemid 30251644)
3. Gardner J, Kennedy HG, Hamblin A, Jones E. HLA associations in sarcoidosis: a study of two ethnic groups. Thorax 1984; 39:19-22. (Pubitemid 14154205)
4. Brennan NJ, Crean P, Long JP, Fitzgerald MX. High prevalence of familial sarcoidosis in an Irish population. Thorax 1984; 39:14-18. (Pubitemid 14154204)
5. El-Zaatari FA, Graham DY, Samuelsson K, Engstrand L. Detection of Mycobacterium avium complex in cerebrospinal fluid of a sarcoid patient by specific polymerase chain reaction assays. Scand J Infect Dis 1997; 29:202-204.
6. Di Alberti L, Piattelli A, Artese L, et al. Human herpesvirus 8 variants in sarcoid tissues. Lancet 1997; 350:1655-1661. (Pubitemid 28036825)
7. Amin DN, Sperber K, Brown LK, et al. Positive Kveim test in patients with coexisting sarcoidosis and human immunodeficiency virus infection. Chest 1992; 101:1454-1456.
8. Maurer TA, Herndier B, McGrath M, et al. Sarcoidosis in a patient with AIDS: a manifestation of immune restoration syndrome. J Am Acad Dermatol 1999; 41 (2 Pt 2):285-286. (Pubitemid 29381995)
9. Bresnitz EA, Stolley PD, Israel HL, Soper K. Possible risk factors for sarcoidosis. A case-control study. Ann N Y Acad Sci 1986; 465:632-642. (Pubitemid 16006603)
10. Burke WM, Keogh A, Maloney PJ, et al. Transmission of sarcoidosis via cardiac transplantation. Lancet 1990; 336:1579-11579.
11. Kern DG, Neill MA, Wrenn DS, Varone JC. Investigation of a unique time-space cluster of sarcoidosis in firefighters. Am Rev Respir Dis 1993; 148 (4 Pt 1):974-980. (Pubitemid 23301216)
12. Rybicki BA, Major M, Popovich J Jr, et al. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997; 145:234-241.
13. Blaise P, Fardeau C, Chapelon C. Minor salivary gland biopsy in diagnosing ocular sarcoidosis. Br J Ophthalmol 2011; 95:1731-1734.
14. Siltzbach LE, James DG, Neville E, et al. Course and prognosis of sarcoidosis around the world. Am J Med 1974; 57:847-852.
15. Baughman RP, Lower EE, Kaufman AH. Ocular sarcoidosis. Semin Respir Crit Care Med 2010; 31:452-462.
16. Oswald-Richter KA, Drake WP. The etiologic role of infectious antigens in sarcoidosis pathogenesis. Semin Respir Crit Care Med 2010; 31:375-379.
17. Kishi J, Nishioka Y, Kuwahara T, et al. Blockade of Th1 chemokine receptors ameliorates pulmonary granulomatosis in mice. Eur Respir J 2011; 38:415-424.
18. Swaisgood CM, Oswald-Richter K, Moeller SD, et al. Development of a sarcoidosis murine lung granuloma model using Mycobacterium superoxide dismutase A peptide. Am J Respir Cell Mol Biol 2011; 44:166-174.
19. Grunewald J. Review: role of genetics in susceptibility and outcome of sarcoidosis. Semin Respir Crit Care Med 2010; 31:380-389.
20. Hance AJ. The role of mycobacteria in the pathogenesis of sarcoidosis. Semin Respir Infect 1998; 13:197-205. (Pubitemid 28440838)
21. Vago L, Barberis M, Gori A, et al. Nested polymerase chain reaction for Mycobacterium tuberculosis IS6110 sequence on formalin-fixed paraffinembedded tissues with granulomatous diseases for rapid diagnosis of tuberculosis. Am J Clin Pathol 1998; 109:411-415. (Pubitemid 28151028)
22. Wilsher ML, Menzies RE, Croxson MC. Mycobacterium tuberculosis DNA in tissues affected by sarcoidosis. Thorax 1998; 53:871-874. (Pubitemid 28459545)
23. Ishige I, Usui Y, Takemura T, Eishi Y. Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet 1999; 354:120-123. (Pubitemid 29313147)
24. Popper HH. Epithelioid cell granulomatosis of the lung: new insights and concepts. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16:32-46. (Pubitemid 29164269)
25. Chan CC, Wetzig RP, Palestine AG, et al. Immunohistopathology of ocular sarcoidosis. Report of a case and discussion of immunopathogenesis. Arch Ophthalmol 1987; 105:1398-1402. (Pubitemid 17149935)
26. Smith MJ, Turton CW, Mitchell DN, et al. Association of HLA B8 with spontaneous resolution in sarcoidosis. Thorax 1981; 36:296-298. (Pubitemid 11156659)
27. Rybicki BA, Maliarik MJ, Major M, et al. Genetics of sarcoidosis. Clin Chest Med 1997; 18:707-717.
28. Ishihara M, Ohno S. Genetic influences on sarcoidosis. Eye (Lond) 1997; 11 (Pt 2):155-161. (Pubitemid 27249905)
29. Berlin M, Fogdell-Hahn A, Olerup O, et al. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1997; 156:1601-1605. (Pubitemid 27505531)
30. Maliarik MJ, Chen KM, Major ML, et al. Analysis of HLA-DPB1 polymorphisms in African-Americans with sarcoidosis. Am J Respir Crit Care Med 1998; 158:111-114. (Pubitemid 28337166)
31. Keller AZ. Hospital, age, racial, occupational, geographical, clinical and survivorship characteristics in the epidemiology of sarcoidosis. Am J Epidemiol 1971; 94:222-230.
32. Takada K, Ina Y, Noda M, et al. The clinical course and prognosis of patients with severe, moderate or mild sarcoidosis. J Clin Epidemiol 1993; 46:359-366. (Pubitemid 23149053)
33. Hunninghake GW, Gilbert S, Pueringer R, et al. Outcome of the treatment for sarcoidosis. Am J Respir Crit Care Med 1994; 149 (4 Pt 1):893-898. (Pubitemid 24108477)
34. Gottlieb JE, Israel HL, Steiner RM, et al. Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy. Chest 1997; 111: 623-631. (Pubitemid 27132936)
35. Fink CW, Cimaz R. Early onset sarcoidosis: not a benign disease. J Rheumatol 1997; 24:174-177. (Pubitemid 27059877)
36. Hoover DL, Khan JA, Giangiacomo J. Pediatric ocular sarcoidosis. Surv Ophthalmol 1986; 30:215-228. (Pubitemid 16175063)
37. De Chadaré vian JP, Raphael SA, Murphy GF. Histologic, ultrastructural, and immunocytochemical features of the granulomas seen in a child with the syndrome of familial granulomatous arthritis, uveitis, and rash. Arch Pathol Lab Med 1993; 117:1050-1052. (Pubitemid 23292038)
38. Tromp G, Kuivaniemi H, Raphael S, et al. Genetic linkage of familial granulomatous inflammatory arthritis, skin rash, and uveitis to chromosome 16. Am J Hum Genet 1996; 59:1097-1107. (Pubitemid 26346351)
39. James DG. A comparison of Blau's syndrome and sarcoidosis. Sarcoidosis 1994; 11:100-101.
40. Spaide RF, Ward DL. Conjunctival biopsy in the diagnosis of sarcoidosis. Br J Ophthalmol 1990; 74:469-471. (Pubitemid 20269090)
41. Erckens RJ, Mostard RLM, Wijnen PAH. Adalimumab successful in sarcoidosis patients with refractory chronic noninfectious uveitis. Graefes Arch Clin Exp Ophthalmol 2012; 250:713-720.
42. Weinreb RN. Diagnosing sarcoidosis by transconjunctival biopsy of the lacrimal gland. Am J Ophthalmol 1984; 97:573-576. (Pubitemid 14146280)
43. Greening AP, Nunn P, Dobson N, et al. Pulmonary sarcoidosis: alterations in bronchoalveolar lymphocytes and T cell subsets. Thorax 1985; 40:278-283. (Pubitemid 15105944)
44. Kosmorsky GS, Meisler DM, Rice TW, et al. Chest computed tomography and mediastinoscopy in the diagnosis of sarcoidosis-associated uveitis. Am J Ophthalmol 1998; 126:132-134. (Pubitemid 28341230)
45. Roulston JE, O'Malley GI, Douglas JG. Effects of prednisolone on angiotensin converting enzyme activity. Thorax 1984; 39:356-360. (Pubitemid 14140405)
46. Baarsma GS, La Hey E, Glasius E, et al. The predictive value of serum angiotensin converting enzyme and lysozyme levels in the diagnosis of ocular sarcoidosis. Am J Ophthalmol 1987; 104:211-217. (Pubitemid 17153168)
47. Stavrou P, Linton S, Young DW, Murray PI. Clinical diagnosis of ocular sarcoidosis. Eye (Lond) 1997; 11 (Pt 3):365-370. (Pubitemid 27344820)
48. Power WJ, Neves RA, Rodriguez A, et al. The value of combined serum angiotensin-converting enzyme and gallium scan in diagnosing ocular sarcoidosis. Ophthalmology 1995; 102:2007-2011. (Pubitemid 26004460)
49. Weinreb RN,Sandman R,Ryder MI, Friberg TR.Angiotensin-converting enzyme activity in human aqueous humor. Arch Ophthalmol 1985; 103:34-36.
50. Philips YL, Eggenberger ER. Neuro-ophthalmic sarcoidosis. Curr Opin Ophthalmol 2010; 21:423-429.
51. Köhn H, Klech H, Mostbeck A, Kummer F. 67Ga scanning for assessment of disease activity and therapy decisions in pulmonary sarcoidosis in comparison to chest radiography, serum ACE and blood T-lymphocytes. Eur J Nucl Med 1982; 7:413-416. (Pubitemid 12015194)
52. Pawate S, Moses H, Sriram S. Presentations and outcomes of neurosarcoidosis: a study of 54 cases. QJM 2009; 102:449-460.
53. Scott TF, Yandora K, Kunschner LJ, Schramke C. Neurosarcoidosis mimicry of multiple sclerosis: clinical, laboratory, and imaging characteristics. Neurologist 2010; 16:386-389.
54. Shetty AK, Zganjar BE, Ellis GS Jr, et al. Low-dose methotrexate in the treatment of severe juvenile rheumatoid arthritis and sarcoid iritis. J Pediatr Ophthalmol Strabismus 1999; 36:125-128. (Pubitemid 29242753)
55. Wallace DJ. The use of chloroquine and hydroxychloroquine for noninfectious conditions other than rheumatoid arthritis or lupus: a critical review. Lupus 1996; 5 (Suppl. 1):S59-S64. (Pubitemid 26196744)
56. Pia G, Pascalis L, Aresu G, et al. Evaluation of the efficacy and toxicity of the cyclosporine A-fluocortolone-methotrexate combination in the treatment of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1996; 13:146-152. (Pubitemid 26332092)
57. Baltzan M, Mehta S, Kirkham TH, Cosio MG. Randomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis. Am J Respir Crit Care Med 1999; 160:192-197. (Pubitemid 29326087)
58. Kaye GB, Salmon JF, Isaacs S. Risk factors for uveitis in sarcoidosis. S Afr Med J 1993; 83:342-344. (Pubitemid 23181459)
59. Rothova A, Alberts C, Glasius E, et al. Risk factors for ocular sarcoidosis. Doc Ophthalmol 1989; 72:287-296. (Pubitemid 20072234)
60. Obenauf CD, Shaw HE, Sydnor CF, Klintworth GK. Sarcoidosis and its ophthalmic manifestations. Am J Ophthalmol 1978; 86:648-655. (Pubitemid 9012789)
61. Kawagoe T, Mizuki N. Sarcoidosis. Curr Opin Ophthalmol 2011; 22:502-507.
62. Karma A. Ophthalmic changes in sarcoidosis. Acta Ophthalmol Suppl 1979; (141):1-94.
63. Jabs DA, Johns CJ. Ocular involvement in chronic sarcoidosis. Am J Ophthalmol 1986; 102:297-301. (Pubitemid 16054936)
64. Rothova A, Buitenhuis HJ, Meenken C, et al. Uveitis and systemic disease. Br J Ophthalmol 1992; 76:137-141.
65. Dresner MS, Brecher R, Henkind P. Ophthalmology consultation in the diagnosis and treatment of sarcoidosis. Arch Intern Med 1986; 146:301-304. (Pubitemid 16018548)
66. Baughman RP, Costabel U, Lower EE. Drug therapy for interstitial lung disease. In: Baughman RP, du Bois RM, editors. Diffuse lung disease: a practical approach. New York, NY: Springer; 2011. pp. 101-120.
67. Bhat P, Cervantes-Castaneda RA, Doctor PP, et al. Mycophenolate mofetil therapy for sarcoidosis-associated uveitis. Ocul Immunol Inflamm 2009; 17:185-190.
68. Androdias G, Maillet D, Marignier R, et al. Mycophenolate mofetil maybe effective in CNS sarcoidosis but not in sarcoid myopathy. Neurology 2011; 76:1168-1172.
69. Moravan M, Segal BM. Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil. Neurology 2009; 72:337-340.
70. Kamphuis LS, Lam-Tse WK, Dik WA, et al. Efficacy of adalimumab in chronically active and symptomatic patients with sarcoidosis. Am J Respir Crit Care Med 2011; 184:1214-1216.
71. Beardsley TL, Brown SV, Sydnor CF, et al. Eleven cases of sarcoidosis of the optic nerve. Am J Ophthalmol 1984; 97:62-77. (Pubitemid 14221010)
72. Mansour AM. Sarcoid optic disc edema and optociliary shunts. J Clin Neuroophthalmol 1986; 6:47-52. (Pubitemid 16101785)
73. Diestelmeier MR, Sausker WF, Pierson DL, Rodman OG. Sarcoidosis manifesting as eyelid swelling. Arch Dermatol 1982; 118:356-357. (Pubitemid 12156123)
74. Sacher M, Lanzieri CF, Sobel LI, Som PM. Computed tomography of bilateral lacrimal gland sarcoidosis. J Comput Assist Tomogr 1984; 8:213-215. (Pubitemid 14169661)
75. Hall JG, Cohen KL. Sarcoidosis of the eyelid skin. Am J Ophthalmol 1995; 119:100-101.
76. Erckens RJ, Mostard RL, Wijnen PA, et al. Adalimumab successful in sarcoidosis patients with refractory chronic noninfectious uveitis. Graefes Arch Clin Exp Ophthalmol 2012; 250:713-720.
77. Bansal R, Gupta V, Gupta A. Current approach in the diagnosis and management of panuveitis [review]. Indian J Ophthalmol 2012; 58:45-54.
78. Agrawal R, Murthy S, Ganesh SK, et al. Cataract Surgery in uveitis. Int J Inflam 2012; 2012:548453; doi: 10.1155/2012/548453.